GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Ryvu Therapeutics RVU.WA · PLN

Health Care · GPW · 🇵🇱 Poland

Compare

16.32

-0.73%

Close of 9 Nov 2026, in PLN

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in PLN, from our data supplier.

FY2025

Revenue

PLN 62.3m

FY2016FY2025

Net income

−PLN 101.2m

FY2016FY2025

Free cash flow

−PLN 117.8m

FY2016FY2025

Shareholders' equity

PLN 53.8m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenuePLN 62.3mPLN 78.0mPLN 46.9mPLN 38.8mPLN 11.2mPLN 15.4mPLN 42.6mPLN 77.2mPLN 87.8mPLN 48.1m
Research and development———PLN 26.0mPLN 15.0mPLN 13.0mPLN 67.6mPLN 53.9mPLN 27.1mPLN 17.3m
Operating income−PLN 122.2m−PLN 122.1m−PLN 100.9m−PLN 78.4m−PLN 78.5m−PLN 35.7m−PLN 45.1m−PLN 13.6mPLN 12.6m−PLN 1.2m
Net income−PLN 101.2m−PLN 111.4m−PLN 92.1m−PLN 83.8m−PLN 79.1m−PLN 31.7m−PLN 36.0m−PLN 106,320PLN 6.4mPLN 2.7m
Diluted earnings per share-4.38-4.82-3.98-4.57-4.31-1.89-2.25-0.010.400.20

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsPLN 224.4mPLN 378.8mPLN 403.2mPLN 475.0mPLN 228.8mPLN 295.6mPLN 182.9mPLN 255.7mPLN 103.6mPLN 89.1m
Cash and short-term investmentsPLN 107.7mPLN 225.4mPLN 233.7mPLN 102.4mPLN 88.2mPLN 161.2mPLN 72.1mPLN 110.4mPLN 36.1mPLN 29.1m
Total liabilitiesPLN 153.7mPLN 234.9mPLN 143.6mPLN 131.6mPLN 59.4mPLN 71.9mPLN 63.1mPLN 60.8mPLN 39.6mPLN 33.4m
DebtPLN 71.7mPLN 75.5mPLN 906,000PLN 2.8mPLN 5.1mPLN 7.4mPLN 9.2mPLN 13.5mPLN 8.0mPLN 9.6m
Shareholders' equityPLN 53.8mPLN 143.9mPLN 259.6mPLN 343.4mPLN 161.3mPLN 223.7mPLN 119.8mPLN 191.9mPLN 62.3mPLN 55.4m
Shares outstanding23m23m23m18m18m17m16m16m16m13m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−PLN 110.3m−PLN 129.5m−PLN 84.5mPLN 21.3m−PLN 57.9m−PLN 10.6m−PLN 17.4m−PLN 36.4mPLN 11.0m−PLN 6.3m
Capital spending−PLN 7.5m−PLN 5.9m−PLN 8.6m−PLN 9.3m−PLN 12.0m−PLN 34.2m−PLN 24.0m−PLN 23.4m−PLN 21.6m−PLN 21.2m
Free cash flow−PLN 117.8m−PLN 135.4m−PLN 93.1mPLN 12.0m−PLN 69.8m−PLN 44.8m−PLN 41.4m−PLN 59.9m−PLN 10.6m−PLN 27.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenuePLN 12.0mPLN 17.0mPLN 18.0mPLN 14.9mPLN 12.4mPLN 16.9mPLN 25.5mPLN 15.1m
Operating income−PLN 16.7m−PLN 12.4m−PLN 24.5m−PLN 29.7m−PLN 27.7m−PLN 37.7m−PLN 40.5m−PLN 26.3m
Net income−PLN 13.1m−PLN 12.6m−PLN 17.6m−PLN 24.7m−PLN 33.7m−PLN 25.3m−PLN 35.1m−PLN 26.6m
Diluted earnings per share-0.56-0.55-0.76-1.07-1.46-1.09-1.52-1.15
Cash from operations−PLN 9.0m−PLN 22.0m−PLN 26.0m−PLN 17.0m−PLN 24.0m−PLN 44.0m−PLN 27.0m−PLN 36.0m
Capital spending——−PLN 4.0m−PLN 1.0m———−PLN 3.0m
Free cash flow——−PLN 30.0m−PLN 18.0m———−PLN 39.0m
Total assetsPLN 182.6mPLN 201.0mPLN 224.4mPLN 255.3mPLN 281.2mPLN 318.5mPLN 378.8mPLN 403.2m
Cash and short-term investments—PLN 79.0mPLN 107.7mPLN 130.7mPLN 150.9mPLN 174.0mPLN 225.4mPLN 245.0m
DebtPLN 73.7mPLN 73.1mPLN 70.8mPLN 69.5mPLN 67.6mPLN 72.9mPLN 74.1mPLN 72.2m
Shareholders' equityPLN 28.4mPLN 41.3mPLN 53.8mPLN 71.2mPLN 95.2mPLN 119.6mPLN 143.9mPLN 177.8m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue17.1%32.2%4.3%
Operating income15.9%27.9%—
Net income6.5%26.1%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-174.2%-187.5%-213.0%-106.2%
Net margin-151.7%-172.0%-197.8%-94.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-6.2-8.0-14.4-10.8-14.2-26.0-20.0-4944.889.287.4
Price to sales10.111.428.423.3100.153.416.96.86.54.9

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.